Lactiga
PrivateLast Round
Series A
Sep 4, 2025
Total Funding Raised
$3.61M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Lactiga is a biotechnology company developing novel mucosal antibodies derived from human breastmilk to address chronic disease and immune dysregulation in vulnerable populations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lactiga Comparables
Compare Lactiga with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Grifols | 71% | |
| Octapharma AG | 67% | |
| Takeda | 66% |
Lactiga Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 4, 2025 | ||||
| Grant | Sep 4, 2025 | ||||
| Grant | Feb 3, 2025 | ||||
| Grant | Sep 21, 2022 | ||||
| Pre Seed | Sep 21, 2022 | ||||
Seed | Nov 2, 2020 |
Key People
Founding team and executive leadership
Lactiga Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Jersey Commission on Science, Innovation and Technology | Grant |
| National Institute of Allergy and Infectious Diseases | Grant |
| Innovation Factory | Grant |
| 1517 Fund | Pre Seed |
| NIH RADx | Grant |
| LaunchYU | Accelerator |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 2479% MoM, reaching 1.1K.
- Feb 3, 2025
Received grant from National Institute of Allergy and Infectious Diseases and NIH RADx.
Lactiga Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Lactiga's valuation, stock price, and market status.
Is Lactiga a public or private company?
Lactiga is a private company.
What is the current stock price of Lactiga?
Lactiga is a private company with no public stock price. No recent secondary market data is available.
How much is Lactiga worth (valuation)?
Valuation information for Lactiga is not publicly available.
Can I buy Lactiga stock?
Lactiga shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Lactiga's last funding round?
Lactiga's most recent funding round was Grant on February 3, 2025.
Who are the main investors in Lactiga?
Key investors in Lactiga include 1517 Fund.
Will Lactiga IPO soon?
No public IPO plans have been announced for Lactiga.
How can I track Lactiga secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lactiga's secondary market activity and sign up for updates.